
Gossamer Bio (GOSS) Financial Statements
Price: $0.9414
Market Cap: $213.91M
Avg Volume: 1.48M
Market Cap: $213.91M
Avg Volume: 1.48M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Gossamer Bio.
Income Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 |
---|---|---|---|---|---|---|---|---|---|
Revenue | $114.70M | $- | $- | $- | $- | $- | $- | $- | $- |
Cost of Revenue | $- | $4.38M | $4.43M | $5.17M | $4.27M | $3.09M | $297.00K | $- | $- |
Gross Profit | $114.70M | $-4.38M | $-4.43M | $-5.17M | $-4.27M | $-3.09M | $-297.00K | $- | $- |
Gross Profit Ratio | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research and Development Expenses | $138.49M | $145.30M | $170.92M | $170.27M | $160.85M | $143.40M | $55.28M | $891.00K | $- |
General and Administrative Expenses | $36.13M | $38.45M | $47.61M | $45.78M | $49.73M | $39.14M | $44.05M | $262.00K | $83.00K |
Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Selling General and Administrative Expenses | $36.13M | $38.45M | $47.61M | $45.78M | $49.73M | $39.14M | $44.05M | $262.00K | $83.00K |
Other Expenses | $- | $- | $1.51M | $799.00K | $-174.00K | $5.83M | $316.00K | $- | $- |
Operating Expenses | $174.62M | $183.76M | $218.53M | $216.05M | $210.58M | $182.54M | $99.33M | $1.15M | $83.00K |
Cost and Expenses | $174.62M | $183.76M | $218.53M | $216.05M | $210.58M | $182.54M | $99.33M | $1.15M | $83.00K |
Interest Income | $1.78M | $2.00M | $1.58M | $761.00K | $3.44M | $3.62K | $1.72M | $- | $- |
Interest Expense | $11.52M | $13.51M | $13.88M | $19.44M | $12.67M | $- | $12.00K | $118.00K | $- |
Depreciation and Amortization | $4.15M | $1.61M | $4.43M | $5.17M | $4.27M | $3.09M | $297.00K | $1.15M | $83.00K |
EBITDA | $-39.97M | $-172.15M | $-211.07M | $-209.32M | $-233.96M | $-186.14M | $-148.99M | $-6.65M | $-83.00K |
EBITDA Ratio | -34.84% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | $-59.92M | $-183.76M | $-218.59M | $-216.12M | $-233.96M | $-186.14M | $-148.99M | $-6.65M | $-83.00K |
Operating Income Ratio | -52.24% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income Expenses Net | $4.28M | $3.94M | $-10.79M | $-17.88M | $-9.40M | $5.83M | $2.02M | $-118.00K | $- |
Income Before Tax | $-55.63M | $-179.82M | $-229.38M | $-234.00M | $-243.36M | $-180.31M | $-146.97M | $-6.77M | $-83.00K |
Income Before Tax Ratio | -48.50% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | $893.00K | $- | $10.85M | $15.07M | $8.22M | $511.00K | $2.04M | $-5.38M | $-83.00K |
Net Income | $-56.53M | $-179.82M | $-240.23M | $-249.08M | $-251.58M | $-180.82M | $-146.97M | $-6.77M | $-83.00K |
Net Income Ratio | -49.28% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | $-0.25 | $-1.18 | $-2.84 | $-3.33 | $-3.67 | $-3.30 | $-2.43 | $-0.27 | $0.00 |
EPS Diluted | $-0.25 | $-1.18 | $-2.84 | $-3.33 | $-3.67 | $-3.30 | $-2.43 | $-0.27 | $0.00 |
Weighted Average Shares Outstanding | 226.23M | 152.62M | 84.57M | 74.84M | 68.51M | 54.74M | 60.40M | 24.83M | 24.83M |
Weighted Average Shares Outstanding Diluted | 226.23M | 152.62M | 84.57M | 74.84M | 68.51M | 54.74M | 60.40M | 24.83M | 24.83M |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 |
---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $46.07M | $32.11M | $111.97M | $183.40M | $486.06M | $135.09M | $105.22M | $315.00K | $60.00K |
Short Term Investments | $248.44M | $264.32M | $143.71M | $141.81M | $26.57M | $266.74M | $123.44M | $- | $- |
Cash and Short Term Investments | $294.52M | $296.43M | $255.68M | $325.22M | $512.63M | $401.83M | $228.66M | $315.00K | $60.00K |
Net Receivables | $5.34M | $- | $- | $- | $- | $- | $- | $- | $- |
Inventory | $- | $- | $- | $-136.00K | $365.00K | $-1.50M | $- | $- | $- |
Other Current Assets | $10.03M | $10.09M | $12.40M | $6.56M | $9.69M | $7.55M | $3.29M | $130.00K | $- |
Total Current Assets | $309.89M | $306.52M | $261.88M | $331.78M | $522.32M | $409.32M | $231.95M | $445.00K | $60.00K |
Property Plant Equipment Net | $5.12M | $4.78M | $9.89M | $10.80M | $16.08M | $15.73M | $3.19M | $- | $- |
Goodwill | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Long Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Non-Current Assets | $283.00K | $618.00K | $680.00K | $1.08M | $1.03M | $1.56M | $4.27M | $- | $- |
Total Non-Current Assets | $5.40M | $5.40M | $10.57M | $11.88M | $17.11M | $17.29M | $7.47M | $- | $- |
Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Assets | $315.29M | $311.92M | $272.45M | $343.66M | $539.43M | $426.60M | $239.42M | $445.00K | $60.00K |
Account Payables | $2.32M | $5.53M | $1.46M | $3.24M | $7.51M | $956.00K | $2.18M | $97.00K | $40.00K |
Short Term Debt | $961.00K | $14.91M | $14.60M | $2.90M | $3.63M | $2.35M | $- | $- | $- |
Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Deferred Revenue | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Current Liabilities | $41.73M | $31.16M | $33.17M | $33.71M | $27.51M | $33.61M | $18.22M | $1.17M | $103.00K |
Total Current Liabilities | $45.01M | $51.60M | $49.23M | $39.86M | $38.65M | $36.92M | $20.40M | $1.27M | $143.00K |
Long Term Debt | $201.92M | $197.55M | $211.14M | $182.34M | $180.10M | $37.20M | $- | $6.04M | $40.00K |
Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Non-Current Liabilities | $38.87M | $- | $- | $- | $- | $- | $339.08M | $1.00K | $- |
Total Non-Current Liabilities | $240.79M | $197.55M | $211.14M | $182.34M | $180.10M | $37.20M | $339.08M | $6.04M | $40.00K |
Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities | $285.80M | $249.15M | $260.37M | $222.19M | $218.75M | $74.12M | $359.49M | $7.31M | $183.00K |
Preferred Stock | $- | $- | $- | $- | $- | $426.60M | $29.20M | $- | $- |
Common Stock | $23.00K | $23.00K | $10.00K | $8.00K | $8.00K | $7.00K | $2.00K | $- | $- |
Retained Earnings | $-1.27B | $-1.21B | $-1.03B | $-811.53M | $-577.53M | $-334.17M | $-153.86M | $-6.89M | $-123.00K |
Accumulated Other Comprehensive Income Loss | $1.19M | $-350.00K | $-574.00K | $45.00K | $599.00K | $258.00K | $-61.00K | $- | $- |
Other Total Stockholders Equity | $1.30B | $1.28B | $1.04B | $932.94M | $897.61M | $686.39M | $29.20M | $32.00K | $- |
Total Stockholders Equity | $29.49M | $62.77M | $-1.03B | $-811.53M | $-577.53M | $-334.17M | $-120.07M | $-6.86M | $-123.00K |
Total Equity | $29.49M | $62.77M | $-1.03B | $-811.53M | $-577.53M | $-334.17M | $-120.07M | $-6.86M | $-123.00K |
Total Liabilities and Stockholders Equity | $315.29M | $311.92M | $-771.85M | $-589.34M | $-358.78M | $-260.05M | $239.42M | $445.00K | $60.00K |
Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $315.29M | $311.92M | $-771.85M | $-589.34M | $-358.78M | $-260.05M | $239.42M | $445.00K | $60.00K |
Total Investments | $248.44M | $264.32M | $143.71M | $141.81M | $26.57M | $266.74M | $123.44M | $- | $- |
Total Debt | $202.88M | $212.46M | $225.74M | $185.24M | $183.73M | $39.55M | $- | $6.04M | $40.00K |
Net Debt | $156.81M | $180.35M | $113.77M | $1.83M | $-302.32M | $-95.54M | $-105.22M | $5.72M | $-20.00K |
Cash Flow Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 |
---|---|---|---|---|---|---|---|---|---|
Net Income | $-56.53M | $-179.82M | $-229.38M | $-234.00M | $-243.36M | $-180.31M | $-146.97M | $-6.77M | $-83.00K |
Depreciation and Amortization | $4.15M | $4.38M | $4.43M | $5.17M | $4.27M | $3.09M | $297.00K | $- | $- |
Deferred Income Tax | $- | $- | $- | $359.00K | $-158.00K | $-2.39M | $- | $- | $- |
Stock Based Compensation | $20.62M | $28.52M | $42.55M | $32.01M | $38.75M | $20.82M | $30.95M | $32.00K | $- |
Change in Working Capital | $39.46M | $-14.84M | $-4.46M | $774.00K | $-3.10M | $10.12M | $15.02M | $994.00K | $103.00K |
Accounts Receivables | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Inventory | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Accounts Payables | $-1.66M | $3.99M | $-1.81M | $-4.43M | $6.98M | $-1.40M | $2.08M | $57.00K | $103.00K |
Other Working Capital | $41.12M | $-18.83M | $-2.65M | $5.20M | $-10.08M | $11.52M | $12.94M | $937.00K | $103.00K |
Other Non Cash Items | $-11.17M | $2.60M | $-177.00K | $6.81M | $27.24M | $3.84M | $49.66M | $32.00K | $103.00K |
Net Cash Provided by Operating Activities | $-3.47M | $-159.16M | $-187.03M | $-188.89M | $-176.36M | $-144.83M | $-51.04M | $-5.75M | $20.00K |
Investments in Property Plant and Equipment | $- | $- | $-475.00K | $-1.62M | $-24.88M | $-6.57M | $-21.21M | $- | $- |
Acquisitions Net | $- | $- | $-65.00K | $75.00K | $23.38M | $3.60M | $-17.72M | $- | $- |
Purchases of Investments | $-494.78M | $-441.67M | $-238.06M | $-152.03M | $-108.97M | $-499.08M | $-123.50M | $- | $- |
Sales Maturities of Investments | $523.80M | $330.70M | $237.50M | $36.23M | $349.19M | $358.50M | $- | $- | $- |
Other Investing Activities | $- | $- | $65.00K | $-75.00K | $-23.38M | $-3.60M | $17.72M | $- | $- |
Net Cash Used for Investing Activities | $29.02M | $-110.97M | $-1.03M | $-117.43M | $215.34M | $-147.14M | $-144.71M | $- | $- |
Debt Repayment | $-12.58M | $-11.61M | $-5.81M | $- | $193.60M | $28.22M | $-40.00K | $6.00M | $40.00K |
Common Stock Issued | $464.00K | $201.32M | $119.95M | $3.33M | $117.11M | $291.31M | $229.55M | $- | $- |
Common Stock Repurchased | $629.00K | $- | $- | $- | $- | $- | $- | $- | $- |
Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Financing Activities | $1.09M | $888.00K | $2.95M | $3.33M | $1.83M | $293.36M | $300.90M | $- | $- |
Net Cash Used Provided by Financing Activities | $-11.49M | $190.15M | $117.09M | $3.33M | $312.54M | $321.58M | $300.86M | $6.00M | $40.00K |
Effect of Forex Changes on Cash | $-102.00K | $110.00K | $-517.00K | $-165.00K | $9.00K | $70.00K | $- | $- | $- |
Net Change in Cash | $13.96M | $-79.86M | $-71.49M | $-303.15M | $351.53M | $29.67M | $105.10M | $255.00K | $- |
Cash at End of Period | $46.07M | $32.11M | $111.97M | $183.47M | $486.62M | $135.09M | $105.42M | $315.00K | $60.00K |
Cash at Beginning of Period | $32.11M | $111.97M | $183.47M | $486.62M | $135.09M | $105.42M | $315.00K | $60.00K | $60.00K |
Operating Cash Flow | $-3.47M | $-159.16M | $-187.03M | $-188.89M | $-176.36M | $-144.83M | $-51.04M | $-5.75M | $20.00K |
Capital Expenditure | $- | $- | $-475.00K | $-1.62M | $-24.88M | $-6.57M | $-21.21M | $- | $- |
Free Cash Flow | $-3.47M | $-159.16M | $-187.51M | $-190.51M | $-201.24M | $-151.40M | $-72.25M | $-5.75M | $20.00K |